113 related articles for article (PubMed ID: 10653164)
1. Cathepsin B and its inhibitor stefin A in brain tumors.
Strojnik T; Zajc I; Bervar A; Zidanik B; Golouh R; Kos J; Dolenc V; Lah T
Pflugers Arch; 2000; 439(3 Suppl):R122-3. PubMed ID: 10653164
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.
Strojnik T; Kos J; Zidanik B; Golouh R; Lah T
Clin Cancer Res; 1999 Mar; 5(3):559-67. PubMed ID: 10100707
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B and its inhibitor stefin A in brain tumors.
Strojnik T; Zajc I; Bervar A; Židanik B; Golouh R; Kos J; Dolenc V; Lah T
Pflugers Arch; 2000 Jan; 439(Suppl 1):r122-r123. PubMed ID: 28176095
[TBL] [Abstract][Full Text] [Related]
4. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
5. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
7. The regulation of cysteine cathepsins and cystatins in human gliomas.
Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT
Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159
[TBL] [Abstract][Full Text] [Related]
8. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath.
Hansen T; Petrow PK; Gaumann A; Keyszer GM; Otto M; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Apr; 14(4):318-24. PubMed ID: 11301348
[TBL] [Abstract][Full Text] [Related]
9. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
[TBL] [Abstract][Full Text] [Related]
10. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
11. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
Werle B; Schanzenbächer U; Lah TT; Ebert E; Jülke B; Ebert W; Fiehn W; Kayser K; Spiess E; Abrahamson M; Kos J
Oncol Rep; 2006 Oct; 16(4):647-55. PubMed ID: 16969475
[TBL] [Abstract][Full Text] [Related]
12. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
Levicar N; Kos J; Blejec A; Golouh R; Vrhovec I; Frkovic-Grazio S; Lah TT
Cancer Detect Prev; 2002; 26(1):42-9. PubMed ID: 12088202
[TBL] [Abstract][Full Text] [Related]
13. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.
Kos J; Krasovec M; Cimerman N; Nielsen HJ; Christensen IJ; Brünner N
Clin Cancer Res; 2000 Feb; 6(2):505-11. PubMed ID: 10690531
[TBL] [Abstract][Full Text] [Related]
14. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis.
Li W; Ding F; Zhang L; Liu Z; Wu Y; Luo A; Wu M; Wang M; Zhan Q; Liu Z
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8753-62. PubMed ID: 16361563
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer.
Li C; Chen L; Wang J; Zhang L; Tang P; Zhai S; Guo W; Yu N; Zhao L; Liu M; Yang S
Oncol Rep; 2011 Oct; 26(4):869-75. PubMed ID: 21667036
[TBL] [Abstract][Full Text] [Related]
18. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression.
Calkins CC; Sloane BF
Biol Chem Hoppe Seyler; 1995 Feb; 376(2):71-80. PubMed ID: 7794528
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cathepsin B and stefin A expression in Gleason pattern 3+3 (score 6) prostate cancer needle biopsies.
Sinha AA; Morgan JL; Wood N; Betre K; Reddy A; Wilson MJ; Ramanani DM
Anticancer Res; 2007; 27(3B):1407-13. PubMed ID: 17595755
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Konduri SD; Yanamandra N; Siddique K; Joseph A; Dinh DH; Olivero WC; Gujrati M; Kouraklis G; Swaroop A; Kyritsis AP; Rao JS
Oncogene; 2002 Dec; 21(57):8705-12. PubMed ID: 12483523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
